432 related articles for article (PubMed ID: 17641146)
1. Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.
Buchanan RW; Freedman R; Javitt DC; Abi-Dargham A; Lieberman JA
Schizophr Bull; 2007 Sep; 33(5):1120-30. PubMed ID: 17641146
[TBL] [Abstract][Full Text] [Related]
2. The neurobiology of cognition in schizophrenia.
Tamminga CA
J Clin Psychiatry; 2006; 67 Suppl 9():9-13; discussion 36-42. PubMed ID: 16965183
[TBL] [Abstract][Full Text] [Related]
3. The neurobiology of cognition in schizophrenia.
Tamminga CA
J Clin Psychiatry; 2006 Sep; 67(9):e11. PubMed ID: 17081078
[TBL] [Abstract][Full Text] [Related]
4. Molecular targets for treating cognitive dysfunction in schizophrenia.
Gray JA; Roth BL
Schizophr Bull; 2007 Sep; 33(5):1100-19. PubMed ID: 17617664
[TBL] [Abstract][Full Text] [Related]
5. New paradigms for treatment development.
Stover EL; Brady L; Marder SR
Schizophr Bull; 2007 Sep; 33(5):1093-9. PubMed ID: 17673495
[TBL] [Abstract][Full Text] [Related]
6. The effects of clozapine on neurocognition: an overview.
Goldberg TE; Weinberger DR
J Clin Psychiatry; 1994 Sep; 55 Suppl B():88-90. PubMed ID: 7525543
[TBL] [Abstract][Full Text] [Related]
7. Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia.
Koola MM; Buchanan RW; Pillai A; Aitchison KJ; Weinberger DR; Aaronson ST; Dickerson FB
Schizophr Res; 2014 Aug; 157(1-3):84-9. PubMed ID: 24878431
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive impairment in schizophrenia and how it affects treatment options.
Bilder RM
Can J Psychiatry; 1997 Apr; 42(3):255-64. PubMed ID: 9114941
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.
Goff DC; Coyle JT
Am J Psychiatry; 2001 Sep; 158(9):1367-77. PubMed ID: 11532718
[TBL] [Abstract][Full Text] [Related]
10. Important steps in the development of cognitive-enhancing drugs in schizophrenia.
Buchanan RW
Am J Psychiatry; 2006 Nov; 163(11):1867-9. PubMed ID: 17074932
[No Abstract] [Full Text] [Related]
11. Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists.
Radek RJ; Kohlhaas KL; Rueter LE; Mohler EG
Curr Pharm Des; 2010 Jan; 16(3):309-22. PubMed ID: 20109141
[TBL] [Abstract][Full Text] [Related]
12. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative.
Carter CS; Barch DM
Schizophr Bull; 2007 Sep; 33(5):1131-7. PubMed ID: 17630405
[TBL] [Abstract][Full Text] [Related]
13. Wayne Fenton's impact on academic neuroscience.
Geyer MA; Tamminga CA
Schizophr Bull; 2007 Sep; 33(5):1156-9. PubMed ID: 17617663
[TBL] [Abstract][Full Text] [Related]
14. Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.
O'Tuathaigh CMP; Moran PM; Zhen XC; Waddington JL
Br J Pharmacol; 2017 Oct; 174(19):3173-3190. PubMed ID: 28667666
[TBL] [Abstract][Full Text] [Related]
15. The role of the α7 nicotinic receptor in cognitive processing of persons with schizophrenia.
AhnAllen CG
Curr Opin Psychiatry; 2012 Mar; 25(2):103-8. PubMed ID: 22262029
[TBL] [Abstract][Full Text] [Related]
16. Drug targets for cognitive enhancement in neuropsychiatric disorders.
Wallace TL; Ballard TM; Pouzet B; Riedel WJ; Wettstein JG
Pharmacol Biochem Behav; 2011 Aug; 99(2):130-45. PubMed ID: 21463652
[TBL] [Abstract][Full Text] [Related]
17. Cognitive neuroscience and schizophrenia: translational research in need of a translator.
Cohen JD; Insel TR
Biol Psychiatry; 2008 Jul; 64(1):2-3. PubMed ID: 18549873
[No Abstract] [Full Text] [Related]
18. [Psychopharmacologic approaches to schizophrenic psychoses].
Giacardy-Paty M; Soubrouillard C; Blin O
Encephale; 1995 Jun; 21 Spec No 3():3-8. PubMed ID: 7628339
[TBL] [Abstract][Full Text] [Related]
19. The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia.
Marder SR
Dialogues Clin Neurosci; 2006; 8(1):109-13. PubMed ID: 16640121
[TBL] [Abstract][Full Text] [Related]
20. [Neuroleptics and nicotine].
Erdmann R
Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
